Pharmacist management of atrial fibrillation in UK primary care: a cross-sectional study

References

• Al-Arkee, S., Mason, J., Fabritz, L., Chua, W., Lane, D., & Jalal, Z. (2021). Pharmacist management of atrial fibrillation: A pilot educational intervention study. European Heart Journal, 42(Supplement_1), ehab724.0544. https://doi.org/10.1093/eurheartj/ehab724.0544
   Google Scholar
• Ashjian, E., Kurtz, B., Renner, E., Yeshe, R., & Barnes, G. D. (2017). Evaluation of a pharmacist-led outpatient direct oral anticoagulant service. American Journal of Health-System Pharmacy, 74(7), 483–489. https://doi.org/10.2146/ajhp151026
   PubMed Web of Science ®Google Scholar
• Bungard, T. J., Gardner, L., Archer, S. L., Hamilton, P., Ritchie, B., Tymchak, W., & Tsuyuki, R. T. (2009). Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Medicine, 3(1), e16–e21.
   PubMedGoogle Scholar
• Center, D. L., & Adams, T. M. (2013). Developing confidence decreases guessing and increases competency. The Journal of Continuing Education in Nursing, 44(9), 389–390. https://doi.org/10.3928/00220124-20130823-35
   PubMed Web of Science ®Google Scholar
• Cohen, E. R., Barsuk, J. H., McGaghie, W. C., & Wayne, D. B. (2013). Raising the bar: Reassessing standards for procedural competence. Teaching and Learning in Medicine, 25(1), 6–9. https://doi.org/10.1080/10401334.2012.741540
   PubMed Web of Science ®Google Scholar
• Collins, S., Barber, A., & Sahm, L. J. (2014). Pharmacist’s counselling improves patient knowledge regarding warfarin, irrespective of health literacy level. Pharmacy, 2(1), 114–123. https://doi.org/10.3390/pharmacy2010114
   Google Scholar
• Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., Wang, S., Alings, M., Xavier, D., Zhu, J., Diaz, R., Lewis, B. S., Darius, H., Diener, H.-C., Joyner, C. D., & Wallentin, L. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 361(12), 1139–1151. https://doi.org/10.1056/NEJMoa0905561
   PubMed Web of Science ®Google Scholar
• Desteghe, L., Engelhard, L., Raymaekers, Z., Kluts, K., Vijgen, J., Dilling-Boer, D., Koopman, P., Schurmans, J., Dendale, P., & Heidbuchel, H. (2016). Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire. International Journal of Cardiology, 223, 906–914. https://doi.org/10.1016/j.ijcard.2016.08.303
   PubMed Web of Science ®Google Scholar
• European Society of Cardiology [ESC]. (2020). 2020 Guidelines for management of atrial fibrillation. ESC Clinical Practice Guidelines. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management
   Google Scholar
• Ghadrdan, E., Mohammadi, M., Namazi, S., Daie, M., & Ebrahimpour, S. (2022). Assessment of pharmacists’ confidence when consulting patients on anticoagulants: A cross-sectional study in Iran. Journal of Pharmaceutical Care, 10(1), 28–33.
   Google Scholar
• Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., Ruzyllo, W., Ruda, M., Koretsune, Y., Betcher, J., Shi, M., Grip, L. T., Patel, S. P., Patel, I., Hanyok, J. J., … Antman, E. M. (2013). Edoxaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 369(22), 2093–2104. https://doi.org/10.1056/NEJMoa1310907
   PubMed Web of Science ®Google Scholar
• Granger, C. B., Alexander, J. H., McMurray, J. J., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., Bahit, M. C., Diaz, R., Easton, J. D., Ezekowitz, J. A., Flaker, G., Garcia, D., Geraldes, M., Gersh, B. J., Golitsyn, S., … Wallentin, L. (2011). Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981–992. https://doi.org/10.1056/NEJMoa1107039
   PubMed Web of Science ®Google Scholar
• GraphPad. (2022). www.graphpad.com.
   Google Scholar
• Gupta, V., Kogut, S. J., & Thompson, S. (2015). Evaluation of differences in percentage of international normalized ratios in range between pharmacist-led and physician-led anticoagulation management services. Journal of Pharmacy Practice, 28(3), 249–255. https://doi.org/10.1177/0897190013516368
   PubMedGoogle Scholar
• Hamedi, N., da Costa, F. A., Horne, R., Levitan, M., Begley, A., & Antoniou, S. (2017). How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants? International Journal of Clinical Pharmacy, 39(6), 1273–1281. https://doi.org/10.1007/s11096-017-0529-0
   PubMed Web of Science ®Google Scholar
• Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007). Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine, 146(12), 857–867. https://doi.org/10.7326/0003-4819-146-12-200706190-00007
   PubMed Web of Science ®Google Scholar
• Information Commissioner’s Office. (2018). Guide to the General Data Protection Regulation (GDPR). https://ico.org.uk/media/for-organisations/guide-to-the-general-data-protection-regulation-gdpr-1-0.pdf.
   Google Scholar
• Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., Hindricks, G., Manolis, A. S., Oldgren, J., Popescu, B. A., Schotten, U., Van Putte, B., Vardas, P., Agewall, S., Camm, J., … Vardas, P. (2016). 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal, 37(38), 2893–2962. https://doi.org/10.1093/eurheartj/ehw210
   PubMed Web of Science ®Google Scholar
• Mikulic, M. (2021). Annual number of pharmacists in the United Kingdom (UK) from 2010 to 2021*. https://www.statista.com/statistics/318874/numbers-of-pharmacists-in-the-uk/
   Google Scholar
• National Institute for Health and Care Excellence [NICE]. (2021). Atrial fibrillation: Diagnosis and management [NG196]. https://www.nice.org.uk/guidance/ng196
   Google Scholar
• Olsson, H. (2014). Measuring overconfidence: Methodological problems and statistical artifacts. Journal of Business Research, 67(8), 1766–1770. https://doi.org/10.1016/j.jbusres.2014.03.002
   Web of Science ®Google Scholar
• Papastergiou, J., Kheir, N., Ladova, K., Rydant, S., De Rango, F., Antoniou, S., Viola, R., Murillo, M. D., Steurbaut, S., & da Costa, F. A. (2017). Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey. International Journal of Clinical Pharmacy, 39(6), 1282–1290. https://doi.org/10.1007/s11096-017-0551-2
   PubMed Web of Science ®Google Scholar
• Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., Becker, R. C., Nessel, C. C., Paolini, J. F., Berkowitz, S. D., Fox, K. A. A., & Califf, R. M. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365(10), 883–891. https://doi.org/10.1056/NEJMoa1009638
   PubMed Web of Science ®Google Scholar
• Peat, J. K., Mellis, C., Williams, K., & Xuan, W. (2020). Health science research: A handbook of quantitative methods. Routledge.
   Google Scholar
• Rudd, K. M., & Dier, J. G. (2010). Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 30(4), 330–338. https://doi.org/10.1592/phco.30.4.330
   Google Scholar
• Shore, S., Ho, P. M., Lambert-Kerzner, A., Glorioso, T. J., Carey, E. P., Cunningham, F., Longo, L., Jackevicius, C., Rose, A., & Turakhia, M. P. (2015). Site-level variation in and practices associated with dabigatran adherence. JAMA, 313(14), 1443–1450. https://doi.org/10.1001/jama.2015.2761
   PubMed Web of Science ®Google Scholar
• Stewart, S., Murphy, N. F., Walker, A., McGuire, A., & McMurray, J. J. (2004). Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart, 90(3), 286–292. https://doi.org/10.1136/hrt.2002.008748
   PubMed Web of Science ®Google Scholar
• Tan, S. L., Yong, Z. Y., Liew, J. E. S., Zainal, H., & Siddiqui, S. (2021). How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia. Journal of Pharmaceutical Policy and Practice, 14(1), 97. https://doi.org/10.1186/s40545-021-00377-w
   PubMed Web of Science ®Google Scholar
• van den Heuvel, J. M., Hövels, A. M., Büller, H. R., Mantel-Teeuwisse, A. K., de Boer, A., & Maitland-van der Zee, A. H. (2018). NOACs replace VKA as preferred oral anticoagulant among new patients: A drug utilization study in 560 pharmacies in The Netherlands. Thrombosis Journal, 16(1), 7. https://doi.org/10.1186/s12959-017-0156-y
   PubMedGoogle Scholar
• Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1987). Atrial fibrillation: A major contributor to stroke in the elderly. Archives of Internal Medicine, 147(9), 1561–1564. https://doi.org/10.1001/archinte.1987.00370090041008
   PubMedGoogle Scholar
• Young, S., Bishop, L., Twells, L., Dillon, C., Hawboldt, J., & O'Shea, P. (2011). Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Family Practice, 12(1), 88. https://doi.org/10.1186/1471-2296-12-88
   PubMedGoogle Scholar